Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of ex Vivo Intra-arterial Methylene Blue Injection on Nodal Staging Accuracy and Survival in Colorectal Cancer.

NCT04842968 is registered in ClinicalTrials.gov with St. Borbala Hospital as lead sponsor.

NCT NCT04842968
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04842968 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of ex Vivo Intra-arterial Methylene Blue Injection on Nodal Staging Accuracy and Survival in Colorectal Cancer.
Lead sponsor
St. Borbala Hospital
Phase
Not applicable
Overall status
Completed
Start date
April 15, 2021
Completion date
September 15, 2021
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer, lymph node metastases